
Yinchuan Arbitration Toy Design Co., Ltd. focuses on developing innovative drugs, particularly in the fields of HIV treatment and human protein production. The company has established a strong competitive edge through its proprietary protein online adsorption technology and has a robust pipeline of products, including the anti-HIV drug Aibond® and various human protein products. With a commitment to advancing drug development and improving accessibility to clinical medications, the company is well-positioned in the pharmaceutical industry, supported by significant government projects and a strong R&D team.

Yinchuan Arbitration Toy Design Co., Ltd. focuses on developing innovative drugs, particularly in the fields of HIV treatment and human protein production. The company has established a strong competitive edge through its proprietary protein online adsorption technology and has a robust pipeline of products, including the anti-HIV drug Aibond® and various human protein products. With a commitment to advancing drug development and improving accessibility to clinical medications, the company is well-positioned in the pharmaceutical industry, supported by significant government projects and a strong R&D team.
What they do: Specialized computing architecture for large-scale graph analytics, AI/ML and memory-bound workloads
Tech differentiator: Patented migrating-thread technology and unified global address space for large-scale unified memory
Headquarters: New York, NY (offices also listed in Palo Alto and South Bend, IN)
Investors / funding: Has received grant funding; listed investors include National Science Foundation, Maulick Capital, Notre Dame Pit Road Fund, Middleburg Capital Development
Memory-bound analytics and large-scale graph analytics for AI/ML workloads
Computing / AI infrastructure
Investment recorded on Crunchbase
“Includes grant funding and multiple investors such as National Science Foundation, Maulick Capital, Notre Dame Pit Road Fund, Middleburg Capital Development”